Home Cart Sign in  
Chemical Structure| 169332-60-9 Chemical Structure| 169332-60-9

Structure of Ac-DEVD-CHO
CAS No.: 169332-60-9

Chemical Structure| 169332-60-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ac-DEVD-CHO functions as a specific Caspase-3 inhibitor, with a Ki value of 230 pM.

Synonyms: Caspase-3 Inhibitor I; N-Ac-Asp-Glu-Val-Asp-CHO

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Zhao, Guangfu ; Tang, Yunhan ; Dan, Ruitong ; Xie, Muhan ; Zhang, Tianci ; Li, Pan , et al.

Abstract: Pasteurella multocida is an important zoonotic respiratory pathogen capable of infecting a diverse range of hosts, including humans, farm animals, and wild animals. However, the precise mechanisms by which P. multocida compromises the pulmonary integrity of mammals and subsequently induces systemic infection remain largely unexplored. In this study, based on mouse and rabbit models, we found that P. multocida causes not only lung damage but also bacteremia due to the loss of lung integrity. Furthermore, we demonstrated that bacteremia is an important aspect of P. multocida pathogenesis, as evidenced by the observed multiorgan damage and systemic inflammation, and ultimately found that this systemic infection leads to a cytokine storm that can be mitigated by IL-6-neutralizing antibodies. As a result, we divided the pathogenesis of P. multocida into two phases: the pulmonary infection phase and the systemic infection phase. Based on unbiased RNA-seq data, we discovered that P. multocida-induced apoptosis leads to the loss of pulmonary epithelial integrity. These findings have been validated in both TC-1 murine lung epithelial cells and the lungs of model mice. Conversely, the administration of Ac-DEVD-CHO, an apoptosis inhibitor, effectively restored pulmonary epithelial integrity, significantly mitigated lung damage, inhibited bacteremia, attenuated the cytokine storm, and reduced mortality in mouse models. At the molecular level, we demonstrated that the FAK-AKT-FOXO1 axis is involved in P. multocida-induced lung epithelial cell apoptosis in both cells and animals. Thus, our research provides crucial information with regard to the pathogenesis of P. multocida as well as potential treatment options for this and other respiratory bacterial diseases.

Keywords: Pasteurella multocida ; apoptosis ; pathogenesis ; FAK-AKT-FOXO1 axis ; pneumonia ; pulmonary integrity ; cytokine storm

Purchased from AmBeed:

Alternative Products

Product Details of Ac-DEVD-CHO

CAS No. :169332-60-9
Formula : C20H30N4O11
M.W : 502.47
SMILES Code : CC([C@@](NC([C@](NC([C@](NC(C)=O)([H])CC(O)=O)=O)([H])CCC(O)=O)=O)([H])C(N[C@@](C=O)([H])CC(O)=O)=O)C
Synonyms :
Caspase-3 Inhibitor I; N-Ac-Asp-Glu-Val-Asp-CHO
MDL No. :MFCD00671412
InChI Key :UMBVAPCONCILTL-MRHIQRDNSA-N
Pubchem ID :644345

Safety of Ac-DEVD-CHO

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Ac-DEVD-CHO

pyroptosis

Isoform Comparison

Biological Activity

Target
  • Caspase-4

    Caspase-4, Ki:132 nM

  • Caspase-3

    Caspase-3, Ki:230 pM

  • Caspase-8

    caspase-8, Ki:0.92 nM

  • Caspase-5

    caspase-5, Ki:205 nM

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.99mL

0.40mL

0.20mL

9.95mL

1.99mL

1.00mL

19.90mL

3.98mL

1.99mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories